BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30274242)

  • 1. Role of KCa3.1 Channels in Modulating Ca
    Catacuzzeno L; Franciolini F
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells.
    Ferreira R; Schlichter LC
    PLoS One; 2013; 8(4):e62345. PubMed ID: 23620825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCa3.1 Channels and Glioblastoma: In Vitro Studies.
    Klumpp L; Sezgin EC; Skardelly M; Eckert F; Huber SM
    Curr Neuropharmacol; 2018; 16(5):627-635. PubMed ID: 28786347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance.
    Sforna L; Megaro A; Pessia M; Franciolini F; Catacuzzeno L
    Curr Neuropharmacol; 2018; 16(5):608-617. PubMed ID: 28875832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of broad cytosolic Ca
    Lee L; Yoast R; Emrich S; Trebak M; Kirk V; Sneyd J
    J Theor Biol; 2024 Mar; 581():111740. PubMed ID: 38253220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kca3.1-Related Cellular Signalling Involved in Cancer Proliferation.
    Calderón Artavia CG; Arvelo Álvarez FA
    Cell Physiol Biochem; 2024 Mar; 58(2):107-127. PubMed ID: 38623063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia, Ion Channels and Glioblastoma Malignancy.
    Michelucci A; Sforna L; Franciolini F; Catacuzzeno L
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescence-based assay to identify modulators of the number of plasma membrane KCa3.1 channels.
    Balut CM; Gao Y; Luke C; Devor DC
    Future Med Chem; 2010 May; 2(5):707-13. PubMed ID: 20596245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K
    Kito H; Kawagishi R; Ryu T; Endo K; Kajikuri J; Giles WR; Ohya S
    J Pharmacol Sci; 2023 Nov; 153(3):142-152. PubMed ID: 37770155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combined tumor irradiation and K
    Stransky N; Ganser K; Quintanilla-Martinez L; Gonzalez-Menendez I; Naumann U; Eckert F; Koch P; Huber SM; Ruth P
    Sci Rep; 2023 Nov; 13(1):20604. PubMed ID: 37996600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells.
    Liu Y; Zhao L; Ma W; Cao X; Chen H; Feng D; Liang J; Yin K; Jiang X
    J Cancer; 2015; 6(7):643-51. PubMed ID: 26078795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.
    Cozzolino M; Panyi G
    Front Pharmacol; 2024; 15():1380655. PubMed ID: 38638868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol eliminates radiation-resistant glioblastoma by re-evoking big conductance calcium-activated potassium channel activity.
    Liu CC; Wu CL; Yeh IC; Wu SN; Sze CI; Gean PW
    Am J Cancer Res; 2021; 11(4):1148-1169. PubMed ID: 33948351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the mediation of Ca
    Lei Z; Wang H; Zhai Y; Sun M; Chen S; Yin P; Wang X
    J Cell Commun Signal; 2023 Dec; 17(4):1309-1321. PubMed ID: 37702818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of Ca
    Becchetti A
    Curr Top Membr; 2023; 92():15-46. PubMed ID: 38007266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate involvement in calcium-dependent migration of astrocytoma cells.
    Hamadi A; Giannone G; Takeda K; Rondé P
    Cancer Cell Int; 2014; 14():42. PubMed ID: 24860258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.
    Brosch PK; Korsa T; Taban D; Eiring P; Hildebrand S; Neubauer J; Zimmermann H; Sauer M; Shirakashi R; Djuzenova CS; Sisario D; Sukhorukov VL
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion.
    Yool AJ; Ramesh S
    Front Pharmacol; 2020; 11():358. PubMed ID: 32292341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of GPR133 (ADGRD1) signaling by its intracellular interaction partner extended synaptotagmin 1.
    Stephan G; Haddock S; Wang S; Erdjument-Bromage H; Liu W; Ravn-Boess N; Frenster JD; Bready D; Cai J; Ronnen R; Sabio-Ortiz J; Fenyo D; Neubert TA; Placantonakis DG
    Cell Rep; 2024 May; 43(5):114229. PubMed ID: 38758649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of GPR133 (ADGRD1) Signaling by its Intracellular Interaction Partner Extended Synaptotagmin 1 (ESYT1).
    Stephan G; Erdjument-Bromage H; Liu W; Frenster JD; Ravn-Boess N; Bready D; Cai J; Fenyo D; Neubert T; Placantonakis DG
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.